Health

Vaccinated, low-risk people won't benefit from COVID-19 pill Paxlovid: Pfizer study suggests


Mounting evidence suggests Paxlovid may not benefit everyone equally. Pfizer’s COVID-19 treatment Paxlovid has been hailed as a breakthrough in the …

Read more

Show More

Related Articles

Back to top button